Clinical trial finds that, while multicomponent strategy did not significantly boost HPV vaccination at fixed time points, initiation rates improved steadily over time
A multicomponent intervention aimed at increasing HPV vaccination rates in pediatric primary care showed a growing effect over time, despite not achieving statistically significant differences at individual time points. The study highlights the importance of sustained system-level support for improving vaccination coverage.
Background
Human papillomavirus (HPV) vaccination is crucial for preventing multiple cancers, yet uptake remains below national targets in the U.S. This study evaluates a systems-focused intervention designed to enhance HPV vaccination initiation and completion rates among children by age 13. Understanding effective strategies for increasing vaccination rates is essential for public health.
Data Highlights
Time Point
Intervention Group (%)
Control Group (%)
24 Months - Initiation
80.1
75.5
24 Months - Completion
52.8
50.1
36 Months - Initiation
82.0
74.6
36 Months - Completion
57.8
49.9
Key Findings
The intervention group showed higher HPV vaccine initiation rates at 24 and 36 months compared to controls.
Completion rates also improved in the intervention group, though not statistically significant after full adjustment.
Clinicians in the intervention group reported increased use of announcement-style communication and higher self-efficacy in addressing parental hesitancy.
COVID-19 pandemic disruptions affected the implementation of the intervention.
Long-term evaluation periods may be necessary to demonstrate measurable improvements in vaccination rates.
Clinical Implications
Healthcare providers should consider implementing multicomponent strategies that include practice facilitation, clinician education, and communication training to improve HPV vaccination rates. Sustained support and evaluation are critical for achieving long-term improvements in vaccination coverage.
Conclusion
The study underscores the complexity of behavior change in vaccination practices and the potential for cumulative gains over time through structured interventions. Continued focus on system-level support is essential for enhancing HPV vaccination uptake.
